New system of scoring IQ tests benefits children with intellectual disabilities
A drug based on a chemical found in garlic can treat diabetes types I and II when taken as a tablet, a study in the new Royal Society of Chemistry journal Metallomics says. When Hiromu Sakurai and colleagues from the Suzuka University of Medical Science, Japan, gave the drug orally to type I diabetic mice,
Full Post: Garlic drug treats diabetes
Parents of children with intellectual disabilities have long been frustrated by IQ testing that tells them little to nothing about their children’s long-term learning potential. That’s because the tests are scored according to the mean performance of children without disabilities, so the raw scores of many intellectually disabled children are converted to the lowest normalized score: typically a zero.
“We send back these reports that don’t tell parents anything about their child,” explained David Hessl, associate professor of clinical psychiatry at the University of California Davis M.I.N.D. Institute.
Now, Hessl and a team of collaborators have devised a new system of scoring IQ tests taken by children with fragile X syndrome, a genetic disorder that causes intellectual disabilities including autism. Their research has just been published online in Springer’s Journal of Neurodevelopmental Disorders.
“If this new method becomes widely available, we will be able to tell parents something more useful and more accurately diagnose and treat young children who are learning disabled,” said Hessl, a physician who cares for children with fragile X syndrome.
According to Hessl, there is a great deal of meaningful variability in the performance of children with intellectual disabilities on IQ tests. Frustrated by IQ tests’ lack of sensitivity, Hessl set out to devise a scoring method that would reveal the strengths and weaknesses of each child.
“I knew a more accurate estimation of the potential of these children would make a big difference in their lives,” he said.
Working with researchers at the M.I.N.D. Institute and Stanford University, as well as a statistician from Pennsylvania State University, the team came up with new normalized scores for 217 children with fragile X syndrome who had undergone IQ testing.
“The new scores tell us more precisely how a child with fragile X syndrome deviates from the normal population in every sub-test area,” Hessl said.
Treatment of fragile X syndrome depends on its manifestations in the individual, and range from behavioral therapy to medication. Widespread use of new normalized scores would allow physicians to better treat their patients.
Hessl concluded, “In the future, the publishers of IQ tests should include lower functioning individuals in their standardization studies. This might mean over-sampling those with intellectual disability in order to get more sensitivity, but it would help so many children.”
1. Hessl D et al. (2008) A solution to limitations of cognitive
testing in children with intellectual disabilities: the case of
fragile X syndrome. Journal of Neurodevelopmental Disorders. DOI
Parents of children with intellectual disabilities have long been frustrated by intelligence quotient (IQ) testing that tells them little to nothing about the long-term learning potential of their children. That’s because these tests are scored according to the mean performance of children without disabilities. The result is that the raw scores of many children with
Full Post: New system of scoring IQ tests taken by children with fragile X syndrome
Writing in this week’s Journal of the American Medical Association , UC Davis M.I.N.D. Institute researchers urge physicians to test for mutations of the fragile X gene in patients of all ages. That’s because, after decades of research, it is clear that mutations in this gene cause a range of diseases, including neurodevelopmental delays and
Full Post: Researchers urge physicians to test for fragile X gene mutations in patients of all ages
A pilot trial of an oral drug therapy called fenobam has shown promising initial results and could be a potential new treatment option for adult patients with Fragile X syndrome (FXS). Findings of the open label, single-dose study by researchers at Rush University Medical Center and the University of California, Davis, Medical Center are to
Full Post: New drug being tested for Fragile X syndrome
Group exercise programs, treadmill training and horseback riding can be healthy choices for children with developmental disabilities, a new review of studies concludes. With these kinds of activities, children with disorders such as autism, mental retardation and cerebral palsy can improve their coordination and aerobic fitness, according to research analyzed by Connie Johnson, PT, a
Full Post: Exercise great for children with developmental disabilities
The use of cardiopulmonary bypass does not cause short-term neurological problems in children and teenagers after surgery for less complex heart defects, according to pediatric researchers. The new finding contrasts favorably with previous studies that showed adverse neurological effects after newborn surgery for more complex heart conditions. “This is good news for school-aged children who
Full Post: Cardiopulmonary bypass for child heart surgery does not affect IQ